 FOSTER CITY, Calif., March 10, 2022 PRNewswire -- Arcellx, Inc. NASDAQ: ACLX, a clinical-stage cell therapy biotechnology company, announced today that chairman and chief executive officer, Rami Elghandour and chief medical officer, Chris Heery, M.D. 